<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li C</submitter><funding>Interdisciplinary Program of Shanghai Jiao Tong University</funding><funding>Science and Technology Commission of Shanghai Municipality</funding><funding>Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission)</funding><funding>Nurture projects for basic research of Shanghai Chest Hospital</funding><pagination>807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8387484</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(9)</volume><pubmed_abstract>The relationship between circular RNA (circRNA) and cancer stem cells (CSCs) is uncertain. We have investigated the combined influence of CSCs, circRNA (hsa_circ_0003222), and immune checkpoint inhibitors in NSCLC progression and therapy resistance. We constructed lung CSCs (LCSCs; PC9 and A549). The effects of hsa_circ_0003222 in vitro were determined by cell counting, colony and sphere formation, and Transwell assays. A tumor xenograft model of metastasis and orthotopic model were built for in vivo analysis. We found that hsa_circ_0003222 was highly expressed in NSCLC tissues and LCSCs. Higher levels of hsa_circ_0003222 were associated with the stage, metastasis, and survival rate of patients with NSCLC. Reduced levels of hsa_circ_0003222 decreased tumor cell proliferation, migration, in</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.</pubmed_title><pmcid>PMC8387484</pmcid><funding_grant_id>18441904700</funding_grant_id><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Chu T</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Hu F</pubmed_authors><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Han B</pubmed_authors><pubmed_authors>Zhong R</pubmed_authors><pubmed_authors>Pan F</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors><pubmed_authors>Nie W</pubmed_authors></additional><is_claimable>false</is_claimable><name>hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.</name><description>The relationship between circular RNA (circRNA) and cancer stem cells (CSCs) is uncertain. We have investigated the combined influence of CSCs, circRNA (hsa_circ_0003222), and immune checkpoint inhibitors in NSCLC progression and therapy resistance. We constructed lung CSCs (LCSCs; PC9 and A549). The effects of hsa_circ_0003222 in vitro were determined by cell counting, colony and sphere formation, and Transwell assays. A tumor xenograft model of metastasis and orthotopic model were built for in vivo analysis. We found that hsa_circ_0003222 was highly expressed in NSCLC tissues and LCSCs. Higher levels of hsa_circ_0003222 were associated with the stage, metastasis, and survival rate of patients with NSCLC. Reduced levels of hsa_circ_0003222 decreased tumor cell proliferation, migration, in</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-05-29T22:30:39.139Z</modification><creation>2025-05-29T22:30:39.139Z</creation></dates><accession>S-EPMC8387484</accession><cross_references><pubmed>34433810</pubmed><doi>10.1038/s41419-021-04095-8</doi></cross_references></HashMap>